Insider · CIK 0001725922
Gaurav Shah
Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing Nov 25, 2024, latest Nov 20, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RCKT: ROCKET PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | ROCKET PHARMACEUTICALS, INC. | $19k 6,276 shares | -1% | +26% from low-80% from high | |
| 40Moderate | ROCKET PHARMACEUTICALS, INC. | $15k 2,253 shares | -0% | +43% from low-69% from high | |
| 40Moderate | ROCKET PHARMACEUTICALS, INC. | $24k 3,621 shares | -0% | +36% from low-70% from high | |
| 61Notable | ROCKET PHARMACEUTICALS, INC. | $102k 20,000 shares | +3% | +3% from low-77% from high | |
| 51Moderate | ROCKET PHARMACEUTICALS, INC. | $145k 11,091 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -6,276 | $2.98 | $19k | 778,296 | Nov 20, 2025 |
| Aug 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | FTax withholding Common Stock | -2,234 | $3.05 | $6,814 | 784,572 | Aug 20, 2025 |
| May 20, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -2,253 | $6.45 | $15k | 786,806 | May 22, 2025 |
| May 16, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -3,621 | $6.53 | $24k | 789,059 | May 20, 2025 |
| Apr 10, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | POpen-market purchase Common Stock | +20,000 | $5.08 | $102k | 792,680 | Apr 14, 2025 |
| Nov 21, 2024 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -11,091 | $13.05 | $145k | 707,328 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.